Back
AbCellera Biologics Quote, Financials, Valuation and Earnings
Sponsored
ABCL
Sponsored
S&P Global: Private Equity Invests $36 Billion Into What?
Read More
Sell
43
ABCL
AbCellera Biologics
Last Price:
4.53
Seasonality Move:
-2.83%
7 Day Trial
ALL ACCESS PASS
$
7
Biden's Oil War: The Administration Is All-In on Green Energy.
Download Free ReportAbCellera Biologics Price Quote
$4.53
+0.03 (+0.67%)
(Updated: March 28, 2024 at 12:20 PM ET)
AbCellera Biologics Key Stats
Sell
43
AbCellera Biologics (ABCL)
is a Sell
Day range:
$4.27 - $4.51
52-week range:
$3.87 - $8.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
34.22
P/B ratio:
1.14%
Volume:
1.3M
Avg. volume:
1.5M
1-year change:
-40.63%
Market cap:
$1.3B
Revenue:
$38M
EPS:
$-0.52
How Much Does AbCellera Biologics Make?
-
How Much Are AbCellera Biologics's Sales Annually?
ABCL Revenues are $38M -
How Much Profit Does AbCellera Biologics's Make A Year?
ABCL net income is -$146.4M
Is AbCellera Biologics Growing As A Company?
-
What Is AbCellera Biologics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.57% -
What Is AbCellera Biologics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
AbCellera Biologics Stock Price Performance
-
Did AbCellera Biologics Stock Go Up Last Month?
AbCellera Biologics share price went down by -12.11% last month -
Did ABCL's Share Price Rise Over The Last Year?
ABCL share price fell by -40.63% over the past 1 year
What Is AbCellera Biologics 52-Week High & Low?
-
What Is AbCellera Biologics’s 52-Week High Share Price?
AbCellera Biologics has traded as high as $8.05 over the past 52 weeks -
What Is AbCellera Biologics’s 52-Week Low Share Price?
AbCellera Biologics has traded as low as $3.87 over the past 52 weeks
AbCellera Biologics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy AbCellera Biologics?
-
How Much Debt Does AbCellera Biologics Have?
Total long term debt quarterly is $0 -
How Much Cash Does AbCellera Biologics Have?
Cash and short term investments quarterly total is $760.6M -
What Is AbCellera Biologics’s Book Value Per Share?
Book value per share is 3.96
Is AbCellera Biologics Cash Flow Positive?
-
What Is ABCL Cash Flow From Operations?
Cash flow from operations (TTM) is -$43.9M -
What Is AbCellera Biologics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $10.4M -
What Is AbCellera Biologics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$221.1M
AbCellera Biologics Return On Invested Capital
-
Is Management Doing A Good Job?
ABCL return on invested capital is -12.26% -
What Is AbCellera Biologics Return On Assets?
ROA measures how assets are converting to revenues and is -9.66% -
What Is ABCL Return On Equity?
ROE is a measure of profitability and is -12.26%
AbCellera Biologics Earnings Date & Stock Price
-
What Is AbCellera Biologics's Stock Price Today?
A single share of ABCL can be purchased today for 4.50 -
What Is AbCellera Biologics’s Stock Symbol?
AbCellera Biologics trades on the nasdaq under the ticker symbol: ABCL -
When Is AbCellera Biologics’s Next Earnings Date?
The next quarterly earnings date for AbCellera Biologics is scheduled on May 3, 2024 -
When Is ABCL's next ex-dividend date?
AbCellera Biologics's next ex-dividend date is March 28, 2024 -
How To Buy AbCellera Biologics Stock?
You can buy AbCellera Biologics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AbCellera Biologics Competitors
-
Who Are AbCellera Biologics's Competitors?
Below is a list of companies who compete with AbCellera Biologics or are related in some way:
AbCellera Biologics Dividend Yield
Data Unavailable
AbCellera Biologics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -33.33% |
Revenue: | -57.4% | -1.24% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 14.75 |
Upside from Last Price: | 227.78% |